A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

Overview of attention for article published in BMC Cancer, March 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 2,454 followers.

A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed #lymphoma #lymsm https://t.co/gtvVWaS6Tl

25 Mar 2021

Reply Repost Favourite

25 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.